2002
DOI: 10.1213/00000539-200209000-00007
|View full text |Cite
|
Sign up to set email alerts
|

The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
41
0
5

Year Published

2003
2003
2013
2013

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 132 publications
(47 citation statements)
references
References 28 publications
1
41
0
5
Order By: Relevance
“…HES 130/0.4 has been reported to have pharmacokinetic and pharmacodynamic advantages such as decreased tissue storage, rapid plasma elimination and low impact on coagulation. 8,9 It was the goal of this prospective study to investigate the effects of intravascular volume replacement with HES 130/0.4 vs a colloid-free volume therapy on pro-and anti-inflammatory cytokines and soluble adhesion molecules in patients undergoing elective major abdominal surgery.…”
Section: Objectifmentioning
confidence: 99%
“…HES 130/0.4 has been reported to have pharmacokinetic and pharmacodynamic advantages such as decreased tissue storage, rapid plasma elimination and low impact on coagulation. 8,9 It was the goal of this prospective study to investigate the effects of intravascular volume replacement with HES 130/0.4 vs a colloid-free volume therapy on pro-and anti-inflammatory cytokines and soluble adhesion molecules in patients undergoing elective major abdominal surgery.…”
Section: Objectifmentioning
confidence: 99%
“…Nevertheless outcome in the pentastarch group was worse due to a higher number of dose-related episodes of renal failure (doubling of creatinine levels), requirement for renal replacement therapy and poorer survival over a 90 day follow up duration [27]. Whilst concerns for safety of starches is not new [28], recent evidence suggests that newer generation of medium molecular weight starches such as HES 130/0.4 do not increase the incidence of acute renal failure [29][30][31]. The higher concentration (10%) starches have a higher waterbinding capacity and hence reduced renal flow [32].…”
Section: Discussionmentioning
confidence: 99%
“…The plasma half life was prolonged by impaired renal function and was common in old age. 11 The mechanism of renal insult following colloid administration has been entitled as acute hyperoncotic renal failure syndrome and it has been attributed to the elevated colloid osmotic pressure, which offsets the hydrostatic glomerular function pressure, leading to reduced urine output. It is more with colloids having high molecular weight and high degree of substitution.…”
Section: Ofmentioning
confidence: 99%